Dr. Toni Brayer Responds to New FDA Requirement to Lower Zolpidem Doses in Sleeping Medication

Posted on Jan 11, 2013 in Wellness

Dr. Toni Brayer, Sutter HealthDr. Toni Brayer, regional vice president and chief medical officer for Sutter Health, spoke with KPIX-TV San Francisco on the FDA’s latest regulation to lower recommended doses of zolpidem for women. Zolpidem is an active ingredient in Ambien and other sleeping medications.

Click here to watch Dr. Brayer’s interview on KPIX-TV San Francisco.

Follow Dr. Brayer’s blog on Sutter Health’s wellness website for women, MyLifeStages.org.

Posted by on Jan 11, 2013 in Wellness | Comments Off on Dr. Toni Brayer Responds to New FDA Requirement to Lower Zolpidem Doses in Sleeping Medication